The Norwegian Nucleoside Analogue Stop Study

Clinical trial NCT03681132 · COMPLETED

Trial details

NCT number: NCT03681132
Sponsor: Oslo University Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hepatitis B, Chronic

Start date: 2018-09-20
Primary completion: 2023-01-31
Enrollment: 127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.